Bettina Kunze1, Frederik Wein1, Hsin-Yu Fang1, Akanksha Anand1, Theresa Baumeister1, Julia Strangmann1, Sophie Gerland1, Jonas Ingermann1, Natasha Stephens Münch1, Maria Wiethaler1, Vincenz Sahm1, Ana Hidalgo-Sastre1, Sebastian Lange1, Charles J Lightdale2, Aqiba Bokhari3, Gary W Falk4, Richard A Friedman5, Gregory G Ginsberg4, Prasad G Iyer6, Zhezhen Jin7, Hiroshi Nakagawa8, Carrie J Shawber9, TheAnh Nguyen10, William J Raab11, Piero Dalerba12, Anil K Rustgi8, Antonia R Sepulveda11, Kenneth K Wang6, Roland M Schmid1, Timothy C Wang8, Julian A Abrams13, Michael Quante14. 1. II. Medizinische Klinik, Technische Universitat München, Munich, Germany. 2. Department of Medicine, Columbia University Irving Medical Center, New York, New York. 3. Yosemite Pathology Medical Group, Modesto, California. 4. Department of Medicine, Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. 5. Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York. 6. Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. 7. Department of Biostatistics, Columbia University Mailman School of Public Health, New York, New York. 8. Department of Medicine, Columbia University Irving Medical Center, New York, New York; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York. 9. Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, New York. 10. Oregon Health and Science University, Portland, Oregon. 11. Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York. 12. Department of Medicine, Columbia University Irving Medical Center, New York, New York; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York; Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, New York. 13. Department of Medicine, Columbia University Irving Medical Center, New York, New York; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York. Electronic address: ja660@cumc.columbia.edu. 14. II. Medizinische Klinik, Technische Universitat München, Munich, Germany. Electronic address: michael.quante@tum.de.
Abstract
BACKGROUND & AIMS: Studies are needed to determine the mechanism by which Barrett's esophagus (BE) progresses to esophageal adenocarcinoma (EAC). Notch signaling maintains stem cells in the gastrointestinal tract and is dysregulated during carcinogenesis. We explored the relationship between Notch signaling and goblet cell maturation, a feature of BE, during EAC pathogenesis. METHODS: We measured goblet cell density and levels of Notch messenger RNAs in BE tissues from 164 patients, with and without dysplasia or EAC, enrolled in a multicenter study. We analyzed the effects of conditional expression of an activated form of NOTCH2 (pL2.Lgr5.N2IC), conditional deletion of NOTCH2 (pL2.Lgr5.N2fl/fl), or loss of nuclear factor κB (NF-κB) (pL2.Lgr5.p65fl/fl), in Lgr5+ (progenitor) cells in L2-IL1B mice (which overexpress interleukin 1 beta in esophagus and squamous forestomach and are used as a model of BE). We collected esophageal and stomach tissues and performed histology, immunohistochemistry, flow cytometry, transcriptome, and real-time polymerase chain reaction analyses. Cardia and forestomach tissues from mice were cultured as organoids and incubated with inhibitors of Notch or NF-kB. RESULTS: Progression of BE to EAC was associated with a significant reduction in goblet cell density comparing nondysplastic regions of tissues from patients; there was an inverse correlation between goblet cell density and levels of NOTCH3 and JAG2 messenger RNA. In mice, expression of the activated intracellular form of NOTCH2 in Lgr5+ cells reduced goblet-like cell maturation, increased crypt fission, and accelerated the development of tumors in the squamocolumnar junction. Mice with deletion of NOTCH2 from Lgr5+ cells had increased maturation of goblet-like cells, reduced crypt fission, and developed fewer tumors. Esophageal tissues from in pL2.Lgr5.N2IC mice had increased levels of RelA (which encodes the p65 unit of NF-κB) compared to tissues from L2-IL1B mice, and we found evidence of increased NF-κB activity in Lgr5+ cells. Esophageal tissues from pL2.Lgr5.p65fl/fl mice had lower inflammation and metaplasia scores than pL2.Lgr5.N2IC mice. In organoids derived from pL2-IL1B mice, the NF-κB inhibitor JSH-23 reduced cell survival and proliferation. CONCLUSIONS: Notch signaling contributes to activation of NF-κB and regulates differentiation of gastric cardia progenitor cells in a mouse model of BE. In human esophageal tissues, progression of BE to EAC was associated with reduced goblet cell density and increased levels of Notch expression. Strategies to block this pathway might be developed to prevent EAC in patients with BE.
BACKGROUND & AIMS: Studies are needed to determine the mechanism by which Barrett's esophagus (BE) progresses to esophageal adenocarcinoma (EAC). Notch signaling maintains stem cells in the gastrointestinal tract and is dysregulated during carcinogenesis. We explored the relationship between Notch signaling and goblet cell maturation, a feature of BE, during EAC pathogenesis. METHODS: We measured goblet cell density and levels of Notch messenger RNAs in BE tissues from 164 patients, with and without dysplasia or EAC, enrolled in a multicenter study. We analyzed the effects of conditional expression of an activated form of NOTCH2 (pL2.Lgr5.N2IC), conditional deletion of NOTCH2 (pL2.Lgr5.N2fl/fl), or loss of nuclear factor κB (NF-κB) (pL2.Lgr5.p65fl/fl), in Lgr5+ (progenitor) cells in L2-IL1B mice (which overexpress interleukin 1 beta in esophagus and squamous forestomach and are used as a model of BE). We collected esophageal and stomach tissues and performed histology, immunohistochemistry, flow cytometry, transcriptome, and real-time polymerase chain reaction analyses. Cardia and forestomach tissues from mice were cultured as organoids and incubated with inhibitors of Notch or NF-kB. RESULTS: Progression of BE to EAC was associated with a significant reduction in goblet cell density comparing nondysplastic regions of tissues from patients; there was an inverse correlation between goblet cell density and levels of NOTCH3 and JAG2 messenger RNA. In mice, expression of the activated intracellular form of NOTCH2 in Lgr5+ cells reduced goblet-like cell maturation, increased crypt fission, and accelerated the development of tumors in the squamocolumnar junction. Mice with deletion of NOTCH2 from Lgr5+ cells had increased maturation of goblet-like cells, reduced crypt fission, and developed fewer tumors. Esophageal tissues from in pL2.Lgr5.N2IC mice had increased levels of RelA (which encodes the p65 unit of NF-κB) compared to tissues from L2-IL1B mice, and we found evidence of increased NF-κB activity in Lgr5+ cells. Esophageal tissues from pL2.Lgr5.p65fl/fl mice had lower inflammation and metaplasia scores than pL2.Lgr5.N2IC mice. In organoids derived from pL2-IL1B mice, the NF-κB inhibitor JSH-23 reduced cell survival and proliferation. CONCLUSIONS: Notch signaling contributes to activation of NF-κB and regulates differentiation of gastric cardia progenitor cells in a mouse model of BE. In human esophageal tissues, progression of BE to EAC was associated with reduced goblet cell density and increased levels of Notch expression. Strategies to block this pathway might be developed to prevent EAC in patients with BE.
Authors: Xiaohong Li; Thomas G Paulson; Patricia C Galipeau; Carissa A Sanchez; Karen Liu; Mary K Kuhner; Carlo C Maley; Steven G Self; Thomas L Vaughan; Brian J Reid; Patricia L Blount Journal: Cancer Prev Res (Phila) Date: 2015-06-30
Authors: Guangchun Jin; Vigneshwaran Ramanathan; Michael Quante; Gwang Ho Baik; Xiangdong Yang; Sophie S W Wang; Shuiping Tu; Shanisha A K Gordon; David Mark Pritchard; Andrea Varro; Arthur Shulkes; Timothy C Wang Journal: J Clin Invest Date: 2009-08-03 Impact factor: 14.808
Authors: Tarek Sawas; Sarah Killcoyne; Prasad G Iyer; Kenneth K Wang; Thomas C Smyrk; John B Kisiel; Yi Qin; David A Ahlquist; Anil K Rustgi; Rui J Costa; Moritz Gerstung; Rebecca C Fitzgerald; David A Katzka Journal: Gastroenterology Date: 2018-08-27 Impact factor: 22.682
Authors: Katia Nones; Nicola Waddell; Nicci Wayte; Ann-Marie Patch; Peter Bailey; Felicity Newell; Oliver Holmes; J Lynn Fink; Michael C J Quinn; Yue Hang Tang; Guy Lampe; Kelly Quek; Kelly A Loffler; Suzanne Manning; Senel Idrisoglu; David Miller; Qinying Xu; Nick Waddell; Peter J Wilson; Timothy J C Bruxner; Angelika N Christ; Ivon Harliwong; Craig Nourse; Ehsan Nourbakhsh; Matthew Anderson; Stephen Kazakoff; Conrad Leonard; Scott Wood; Peter T Simpson; Lynne E Reid; Lutz Krause; Damian J Hussey; David I Watson; Reginald V Lord; Derek Nancarrow; Wayne A Phillips; David Gotley; B Mark Smithers; David C Whiteman; Nicholas K Hayward; Peter J Campbell; John V Pearson; Sean M Grimmond; Andrew P Barbour Journal: Nat Commun Date: 2014-10-29 Impact factor: 14.919
Authors: Amitabh Srivastava; Kevin L Golden; Carissa A Sanchez; Karen Liu; Pui Yee Fong; Xiaohong Li; David S Cowan; Peter S Rabinovitch; Brian J Reid; Patricia L Blount; Robert D Odze Journal: PLoS One Date: 2015-07-31 Impact factor: 3.240
Authors: Julian A Abrams; Armando Del Portillo; Caitlin Hills; Griselda Compres; Richard A Friedman; Bin Cheng; John Poneros; Charles J Lightdale; Rachel De La Rue; Massimiliano di Pietro; Rebecca C Fitzgerald; Antonia Sepulveda; Timothy C Wang Journal: Cancer Prev Res (Phila) Date: 2021-03-29
Authors: Uma M Sachdeva; Masataka Shimonosono; Samuel Flashner; Ricardo Cruz-Acuña; Joel T Gabre; Hiroshi Nakagawa Journal: Cancer Lett Date: 2021-04-07 Impact factor: 9.756
Authors: Bettina Kunze; Moritz Middelhoff; H Carlo Maurer; Tatiana Agibalova; Akanksha Anand; Anne-Marie Bührer; Hsin-Yu Fang; Theresa Baumeister; Katja Steiger; Julia Strangmann; Roland M Schmid; Timothy C Wang; Michael Quante Journal: Sci Rep Date: 2021-02-24 Impact factor: 4.379
Authors: Andrea Proaño-Vasco; Theresa Baumeister; Amira Metwaly; Sandra Reitmeier; Karin Kleigrewe; Chen Meng; Michael Gigl; Thomas Engleitner; Rupert Öllinger; Roland Rad; Katja Steiger; Akanksha Anand; Julia Strangmann; Robert Thimme; Roland M Schmid; Timothy C Wang; Michael Quante Journal: Microorganisms Date: 2021-11-25